Covid-19 Response from VectorB2B


By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Since the COVID-19 pandemic, VectorB2B has created new partnerships with service providers to help you develop your products reliably. Whether you are working on vaccines, antivirals, antibody therapies, repellents or equipment, you will find the models, screening, products, and services you need across our portfolio that will make your programs a success.

In Vitro Screening

Depending on your product´s mechanism of action, these can be added at different points in the study – before, during, or after viral infection of cells, or pre-incubation with the virus before infecting cells. Relevant screening includes:

  • Expedited in vitro antiviral assay to screen novel and existing antiviral therapies against a set of virus strains
  • Positive hits testing against the BSL-3 SARS-CoV-2 pandemic strain
  • In vitro assays (cell-based assays and cytotoxicity assays)
  • Clearance or inactivation studies (analyzing efficiency of inactivation procedures)


We also have an experienced team that can provide medical writing services, regulatory support, clinical protocol writing or other services to help you develop your product in a more reliable way.


The following text contains information in Portuguese:

Apresentamos para as empresas portuguesas o Desconfinamento 360º.

Esta oferta é única no mercado e irá garantir à sua empresa o acesso nas suas instalações às mais inovadoras técnicas e testes serológicos (anticorpos) e de diagnóstico para a COVID19. 

Potenciando a retoma à normalidade, alavancando a economia, criando sentimento de segurança nos colaboradores, fornecedores e principalmente clientes.

Os testes são certificados; a recolha de sangue ou swabs é feita por profissionais credenciados para o efeito. O tratamento de dados é estritamente confidencial e de acordo com o RGPD.

What support do you need with Covid-19?